Study platform for brain metastases in solid cancers
Part of Brain & nervous system, Cancer clinical trials.
This trial studies people with solid tumors that have spread to the brain (including the brain lining) to help researchers learn what works and how best to treat it. You may be asked for blood/tissue samples and a procedure to collect spinal fluid when brain metastases are diagnosed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 years or older
- You can take care of yourself fairly well (ECOG 0–2)
- You have a qualifying cancer type that has spread to the brain, or to the brain for the first time
- You can provide saved tumor tissue from the original tumor or non-brain spread
- You can have a lumbar puncture (spinal fluid test) around the time brain metastases are diagnosed
- Your expected lifespan is more than 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects samples of spinal fluid and blood from people with solid tumours that have spread to the brain or spine, or who have primary brain tumours. The goal is see if these samples can help doctors detect and monitor these cancers more easily.
This trial tests a new drug called MT027 for people whose solid tumors (like lung or breast cancer) have spread to the brain, spinal cord, or their protective lining. The goal is to see if it is safe and helps shrink or control these metastases.
This trial tests tumor samples from brain metastases to see which drug might work best for you. It aims to guide your next treatment when standard options are limited.
This study looks at how solid tumors spread to the lining of the brain and spinal cord. It aims to understand this condition better by reviewing patient records.
This study is for people with breast cancer that has spread to the lining of the brain or spinal cord (called leptomeningeal metastasis). Researchers want to understand how to treat this condition and offer care to those who qualify.
This trial is for people with cancer that has spread to the brain (brain metastases). It tests a new approach where you start a systemic therapy (drugs that travel through your body) and later add focused radiation to the brain tumors, instead of treating them right away. The goal is to see if this sequence works well and avoids unnecessary side effects.
Hear when a new CNS Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.